PFE vs MRK
Two big pharma dividend payers — a high-yield reset story versus a steadier dividend grower. Here’s how PFE and MRK compare for dividend investors — with a calculator for each so you can model the income yourself.
PFE
Pfizer Inc.
- Type
- High-yield stock
- Issuer
- Pfizer
- Pays
- quarterly
Pfizer is one of the largest global pharmaceutical companies, with a broad portfolio of vaccines and branded medicines. It pays a quarterly dividend that, after the run-down of pandemic-era revenue, has carried a notably high yield relative to its large-cap peers.
PFE dividend calculatorMRK
Merck & Co., Inc.
- Type
- Dividend-growth stock
- Issuer
- Merck
- Pays
- quarterly
Merck is a major global pharmaceutical company known for vaccines, oncology, and animal-health products. It pays a quarterly dividend and has a multi-year record of annual increases.
MRK dividend calculatorHow PFE and MRK differ
PFE — Pfizer is one of the largest global pharmaceutical companies, with a broad portfolio of vaccines and branded medicines. It pays a quarterly dividend that, after the run-down of pandemic-era revenue, has carried a notably high yield relative to its large-cap peers.
MRK — Merck is a major global pharmaceutical company known for vaccines, oncology, and animal-health products. It pays a quarterly dividend and has a multi-year record of annual increases.
In practice the choice comes down to your goal. PFE suits an investor who wants a high current yield from a single company, with limited dividend growth, while MRK suits one who wants income from this strategy. The two are not mutually exclusive — plenty of portfolios hold a growth-oriented fund and an income-oriented one together. What matters is matching each to its job and not judging a fund on its headline yield alone.
Rather than compare a single snapshot yield (which moves daily), open each calculator and enter current figures: the PFE calculator and the MRK calculator. To compare long-term compounding head to head, run the same contributions through the dividend reinvestment calculator with each fund’s assumptions.
PFE vs MRK FAQ
- What's the main difference between PFE and MRK?
- PFE is a high-yield stock from Pfizer; MRK is a dividend-growth stock from Merck. Two big pharma dividend payers — a high-yield reset story versus a steadier dividend grower.
- Does PFE or MRK pay more dividends?
- It depends on current figures, which change — use the calculators linked below with each fund's live yield rather than a fixed number. As a rule, higher-yield funds pay more today, while dividend-growth funds start lower and raise the payout over time.
- Which is better, PFE or MRK?
- Neither is universally better — they suit different goals. PFE fits an investor who wants a high current yield from a single company, with limited dividend growth; MRK fits one who wants income from this strategy. Match the fund to your objective, time horizon, and tax situation, and consider a licensed advisor.
- Can I hold both PFE and MRK?
- Many investors do, to blend current income with growth. Just be aware of overlap — if both hold similar large-cap US stocks, you may be less diversified than the two tickers suggest.